(Q24536249)

5 July 2017

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection (English)

1 reference

5 July 2017

0 references

Felipe García

10

Felipe

García

1 reference

19 October 2023

Huldrych F Günthard

3

Huldrych F

Günthard

1 reference

19 October 2023

David A Price

2

David A

Price

1 reference

19 October 2023

11

Bernard Hirschel

Bernard

Hirschel

1 reference

5 July 2017

1

Annette Oxenius

Annette

Oxenius

1 reference

5 July 2017

Sara J Dawson

4

Sara J

Dawson

1 reference

5 July 2017

Catherine Fagard

5

Catherine

Fagard

1 reference

5 July 2017

Luc Perrin

6

Luc

Perrin

1 reference

5 July 2017

Marek Fischer

7

Marek

Fischer

1 reference

5 July 2017

Rainer Weber

8

Rainer

Weber

1 reference

5 July 2017

Montserrat Plana

9

Montserrat

Plana

1 reference

5 July 2017

Angela McLean

12

Angela

McLean

1 reference

5 July 2017

Rodney E Phillips

13

Rodney E

Phillips

1 reference

5 July 2017

language of work or name

English

0 references

publication date

7 October 2002

1 reference

Proceedings of the National Academy of Sciences of the United States of America

5 July 2017

1 reference

5 July 2017

99

1 reference

5 July 2017

13747-13752

1 reference

5 July 2017

21

1 reference

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

5 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

HIV preferentially infects HIV-specific CD4+ T cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Metabolic complications associated with antiretroviral therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Host determinants in HIV infection and disease. Part 1: cellular and humoral immune responses

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Structured treatment interruptions to control HIV-1 and limit drug exposure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

The CD4(+) T cell response to HIV-1.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

Rapid effector function in CD8+ memory T cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=129766

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

30 May 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

Control of HIV despite the Discontinuation of Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

Immune control of HIV-1 after early treatment of acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

PUBLIC HEALTH: HIV/AIDS Treatment for Millions

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202372199

21 January 2018

Identifiers

DOI

10.1073/PNAS.202372199

1 reference

release_qsv3i5agpzew5krk6ura54d7ui

5 July 2017

0 references

0 references

PMCID

129766

1 reference

5 July 2017

1 reference